MedTrace Logo

Efficacy Trial of a Dissonance Based Eating Disorder Program

NCT03796091 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 180

Last updated 2022-12-09

Study results available
· View outcomes & findings →

Summary

The purpose of this clinical trial is to investigate whether symptoms of disordered eating change among participants who complete an intervention. Participants will be randomly assigned to one of three intervention conditions and will undergo assessments of symptoms before, after, and 2 months after each intervention. Investigators are evaluating which interventions are most effective in reducing eating disorder symptoms and disorder-related psychological and cardiac risk factors.

Conditions

  • Eating Disorder

Interventions

BEHAVIORAL

Educational Brochure

Participants will read an educational brochure from the National Eating Disorders Association and will receive treatment referral resources.

BEHAVIORAL

Body Project Traditional

Participants will complete a 1-hour per week group therapy program for 4 weeks consisting of the Body Project Traditional group therapy program (see Stice \& Shaw, 2001).

BEHAVIORAL

Body Project Expanded

Participants will complete a 1-hour per week group therapy program for 4 weeks consisting of the Body Project Expanded group therapy program (see Green et al., 2017).

Sponsors & Collaborators

  • National Institute of Mental Health (NIMH)

    collaborator NIH

  • Cornell College

    lead OTHER

Principal Investigators

  • Melinda A Green, PhD · Green Counseling Services PLLC

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
15 Years
Max Age
34 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-11-18
Primary Completion
2021-04-15
Completion
2021-04-15

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03796091 on ClinicalTrials.gov